Search Results - "Pirson, Y"

Genetics of hypercalciuric stone forming diseases by Devuyst, O., Pirson, Y.

“…With a lifetime incidence of up to 12% in man and 6% in woman, nephrolithiasis is a major health problem worldwide. Approximately, 80% of kidney stones are…”
Get full text

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data by Temmerman, F., Gevers, T., Ho, T. A., Vanslembrouck, R., Coudyzer, W., Pelt, J., Bammens, B., Pirson, Y., Drenth, J. P., Nevens, F.

“…Summary Background Long‐acting lanreotide (LAN) 120 mg every 4 weeks reduces liver volume (LV) in patients with polycystic liver diseases (PCLD). Animal…”
Get full text

Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation by Scheers, I., Sokal, E., Limaye, N., Denoncin, C., Stephenne, X., Pirson, Y., Godefroid, N.

“…Familial hypocalciuric hypercalcemia is an autosomal dominant genetic disorder characterized by hypercalcemia associated with inappropriate hypocalciuria and…”
Get full text

Management of cerebral aneurysms in autosomal dominant polycystic kidney disease by PIRSON, Yves, CHAUVEAU, Dominique, TORRES, Vicente

Get full text

Outcome of hepatitis B and C virus‐associated hepatocellular carcinoma occurring after renal transplantation by Kanaan, N., Raggi, C., Goffin, E., De Meyer, M., Mourad, M., Jadoul, M., Beguin, C., Kabamba, B., Borbath, I., Pirson, Y., Hassoun, Z.

“…Summary Kidney transplant recipients (KTR) are subjected to immunosuppressive therapy that can enhance hepatitis B and C virus replication, leading to…”
Get full text

O085 : Lanreotide reduces liver volume yet accelerates muscle wasting and weight loss in symptomatic polycystic liver disease by Temmerman, F, Ho, T.A, Vanslembrouck, R, Coudyzer, W, Billen, J, Dobbels, F, van Pelt, J, Bammens, B, Pirson, Y, Nevens, F

Get full text

P883 DEVELOPMENT AND VALIDATION OF A POLYCYSTIC LIVER DISEASE COMPLAINT SPECIFIC ASSESSMENT (POLCA) by Temmerman, F, Dobbels, F, van Pelt, J, Ho, T, Pirson, Y, Vanslembrouck, R, Coudyzer, W, Bammens, B, Pirenne, J, Nevens, F

Get full text

Modifier effect of ENOS in autosomal dominant polycystic kidney disease by PERSU, A, STOENOIU, M. S, WATTIEZ, R, PIRSON, Y, CHAUVEAU, D, LENS, X. M, DEVUYST, O, MESSIAEN, T, DAVILA, S, ROBINO, C, EL-KHATTABI, O, MOURAD, M, HORIE, S, FERON, O, BALLIGAND, J.-L

“…A significant phenotypical variability is observed in autosomal dominant polycystic kidney disease (ADPKD). ADPKD is associated with altered…”
Get full text

Weight loss in a patient with polycystic kidney disease: when liver cysts are no longer innocent bystanders by Cecere, N., Hakem, S., Demoulin, N., Hubert, C., Jabbour, N., Goffette, P., Pirson, Y., Morelle, J.

“…Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent inherited kidney disorder, and liver involvement represents one of its major…”
Get full text

1395 THE REDUCTION IN LIVER VOLUME IN POLYCYSTIC LIVER DISEASE WITH LANREOTIDE IS DOSE DEPENDENT AND IS MOST PRONOUNCED IN PATIENTS WITH THE HIGHEST LIVER VOLUME by Temmerman, F, Vanslembrouck, R, Coudyzer, W, Bammens, B, Laleman, W, Cassiman, D, van der Merwe, S, Verslype, C, Van Steenbergen, W, van Pelt, J, Pirson, Y, Drenth, J, Nevens, F

Get full text

432 CA19.9 AS A DIAGNOSTIC MARKER FOR HEPATIC CYST INFECTION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE by Hassoun, Z, Goffin, E, Pirson, Y, Devuyst, O, Kanaan, N

Get full text

ACUTE OXALATE NEPHROPATHY AFTER RENAL TRANSPLANTATION by Mazzoleni, L, Aydin, S, De Meyer, M, Pirson, Y, Kanaan, N

“…Measures to reduce hyperoxaluria and prevent graftoxalosis must be taken including a low-oxalate and fat diet, oral calcium supplements, high fluid intake, and…”
Get full text

Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2 : Two facets of the same disease? by DAHAN, Karin, FUCHSHUBER, Arno, ADAMIS, Stavroula, SMAERS, Michèle, KROISS, Sabine, LOUTE, Guy, COSYNS, Jean-Pierre, HILDEBRANDT, Friedhelm, VERELLEN-DUMOULIN, Christine, PIRSON, Yves

“…Familial juvenile hyperuricemic nephropathy (FJHN) is an autosomal dominant disorder heralded by hyperuricemia during childhood; it is characterized by chronic…”
Get full text

813 RESULTS OF LIVER TRANSPLANTATION IN ADULT POLYCYSTIC LIVER DISEASE: REPORT OF A SINGLE CENTER EXPERIENCE by Patris, A, Bonaccorsi-Riani, E, Ciccarelli, O, Goffette, P, Pirson, Y, Lerut, J, Hassoun, Z

Get full text

Outcome of kidney transplantation in familial juvenile hyperuricaemic nephropathy by Labriola, Laura, Dahan, Kar in, Pirson, Yves

Get full text

ADVANCES IN GENETIC DISEASES OF THE KIDNEY: IMPACT ON RENAL MEDICINE by Pirson, Y.

Get full text

Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen by Bachner, L, Schärer, K, Kääriäinen, H, von Mühlendahl, K. E, Zerres, K, Deschennes, G, Steinbicker, V, Eggermann, T, Rudnik-Schöneborn, S, Mücher, G, Knapp, M, Neumann, H. P. H, Wirth, B, Misselwitz, J, Pirson, Y, Lennert, T

“…Autosomal recessive polycystic kidney disease (ARPKD) is one of the major hereditary nephropathies in children predominantly presenting in early childhood. The…”
Get full text

Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action by Pirson, Yves

Get full text

PRE-TERMINAL RENAL INSUFFICIENCY IN A PATIENT WITH ENTERIC HYPEROXALURIA: EFFECT OF MEDICAL MANAGEMENT ON RENAL FUNCTION by PIPELEERS, L, WISSING, K. M, PIRSON, Y, COSYNS, J. P, GEERS, C, TIELEMANS, C

“…Enteric hyperoxaluria causes tubular deposition calcium oxalate crystals and severe chronic interstitial nephritis. We describe a patient with pre-terminal…”
Get full text

The diabetic patient with ESRD : how to select the modality of renal replacement by PIRSON, Y

Get full text